Menu

Taysha Gene Therapies, Inc. TSHA

Full chart Compare
Set alert

Price alert · TSHA

All alert types
4.37 USD +0.04 (+0.92%)

At closeNov 10, 2026, 4:00 AM EST

4.52 +0.15 +3.46%

Pre-market · Nov 10, 4:00 AM ET

4.25 Day range 4.53
3.46 52-week range 7.30
YTD
-20.55%
1 year
+12.34%

Revenue & Expenses

Other Income → Expenses: $1.50MExpenses → Selling, General & Admin: $33.87MExpenses → Research & Development: $86.40MGross Profit → Expenses: $9.77MRevenue → Gross Profit: $9.77MNet Loss → Expenses: $109.00MOther Income$1.50MGross Profit$9.77MNet Loss$109.00MExpenses$120.27MSelling, General & Admin$33.87MResearch & Development$86.40MRevenue$9.77M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

TSHA annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
9.77M8.33M15.45M2.50M0
9.77M8.33M15.45M2.50M0
9.77M8.33M15.45M2.50M0
120.27M99.79M87.89M164.95M173.27M
86.40M66.00M56.78M91.17M131.94M
33.87M28.95M30.05M37.36M41.32M
-110.50M-91.46M-72.44M-162.45M-173.27M
63.00K102.00K5.00M3.80M1.43M
-109.00M-89.30M-111.57M-166.01M-174.52M
-109.00M-89.30M-111.57M-166.01M-174.52M
-109.00M-89.30M-111.57M-166.01M-174.52M
-109.00M-89.30M-111.57M-166.01M-174.52M
-0.34-0.36-0.96-3.78-4.64
-0.34-0.36-0.96-3.78-4.64
-0.34-0.36-0.96-3.78-4.64
-108.93M-89.20M-106.57M-162.22M-173.09M
-108.93M-89.20M-106.57M-162.22M-173.09M
319.71M250.13M116.12M43.95M37.65M
319.71M250.13M116.12M43.95M37.65M